American Dining Creations company information, Employees & Contact Information

BofA Securities Maintains Agree Realty Corp(ADC.US) With Buy Rating, Raises Target Price to $90 富途牛牛

The Updated Clinical Results for PD-L1 ADC HLX43 at the 2025 WCLC, Demonstrate Outstanding Efficacy in NSCLC 复宏汉霖

Truist Financial Maintains Agree Realty Corp(ADC.US) With Buy Rating, Announces Target Price $82 富途牛牛

Release of the Updated Abstract for Henlius’ PD-L1 ADC HLX43 at 2025 WCLC-Media 复宏汉霖

FM 50 2017: 22. American Dining Creations/American Food & Vending FoodService Director

RBC Capital Maintains Agree Realty Corp(ADC.US) With Buy Rating, Raises Target Price to $80 富途牛牛

Henlius to Present Latest Results on ADC and IO Therapies in Lung Cancer at 2025 WCLC-Media 复宏汉霖

Stifel Maintains Agree Realty Corp(ADC.US) With Buy Rating, Raises Target Price to $81 富途牛牛

Henlius' HLX43, a Novel PD-L1 ADC, Advances to Phase 2 Clinical Trials with First Patient Dosed 复宏汉霖

Truist Financial Initiates Agree Realty Corp(ADC.US) With Buy Rating 富途牛牛

Henlius Receives the NMPA IND Approval for Its PD-L1-Targeting ADC HLX43 in Combination with Novel Anti-PD-1 mAb Serplulimab-Media 复宏汉霖

Barclays Maintains Agree Realty Corp(ADC.US) With Hold Rating, Maintains Target Price $77 富途牛牛

Henlius Receives IND Approval from NMPA for a Phase 1b/2 Clinical Trial of Its Novel PD-L1-Targeting ADC HLX43 复宏汉霖

Henlius to Make Its Debut at the World ADC Asia 2024-Media 复宏汉霖

Henlius Shines at World ADC Asia 2024, Showcasing Its Innovative R&D Accomplishments in ADC Area 复宏汉霖

First Subject Dosed for Phase 1 Clinical Trial of Henlius’ ADC Candidate HLX42-Media 复宏汉霖

Henlius Receives the FDA IND Approval for Its PD-L1-Targeting ADC Candidate HLX43-Media 复宏汉霖

Henlius Announces NMPA Approvals of Two ADC Candidates for IND-Media 复宏汉霖

First Subject Dosed for Phase 1 Clinical Trial of Henlius’ ADC Candidate HLX43-Media 复宏汉霖

Contact ADC Legal American-Arab Anti-Discrimination Committee

‘No further re-underwriting of the casualty book’ needed: Everest CFO Insurance Insider US

U.S. Department of Education Orders Relief for Palestinian and Arab Students at Rutgers University Following ADC Complaint American-Arab Anti-Discrimination Committee

Results From the Preclinical Study of HLX42, a Potential BIC EGFR-Targeting ADC Released at 2023 ESMO 复宏汉霖

Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial AstraZeneca US

Corbus posts first US data on challenger to Pfizer’s ADC Padcev Fierce Biotech

Results From the Preclinical Study of HLX43, a Potential FIC PD-L1-Targeting ADC Released at 2023 ESMO 复宏汉霖

OS Therapies sets up subsidiary to seek ADC joint ventures with US, China peers Fierce Biotech

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors PR Newswire

GSK receives US FDA Breakthrough Therapy Designation for its B7-H3-targeted antibody-drug conjugate in relapsed or refractory extensive-stage small-cell lung cancer GSK

ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK GlobeNewswire

Adcendo broadens ADC pipeline in US$1bn biobucks deal European Biotechnology Magazine

Arab Americans gather for national convention in Dearborn with Garlin Gilchrist, Ro Khanna Detroit Free Press

ADC Therapeutics to Present at November Investor Conferences – Company Announcement Financial Times

Radiance rolls into ROR1 race, paying $15M for ADC rival to Merck’s frontrunner Fierce Biotech

These Cancer Drugs Work Better Than Chemo, with Fewer Side Effects Scientific American

Whirlpool Recalls Stacked Commercial Clothes Dryers Sold Under the ADC Brand Due to Fire Hazard (Recall Alert) U.S. Consumer Product Safety Commission (.gov)

Antibody Drug Conjugates [ADC] Market Size to Surpass US$ 24.70 Billion by 2032, Driven by Breakthroughs in Targeted Cancer Therapies | Research by SNS Insider Yahoo Finance

James Abourezk, first Arab American U.S. senator and founder of the ADC, dies at 92 ArabAmericanNews

In $435M deal, ADC Therapeutics taps Sobi to market Zynlonta outside of the US Fierce Pharma

Lotte outlines ambitious U.S. plans for ADC, CDMO businesses Korea JoongAng Daily

pay-customs-tariffs-with-adc-portal-service DHL

ADC, US-DFC Sign MoU To Build Data Centre DailyGuide Network